Guest guest Posted August 31, 2006 Report Posted August 31, 2006 CD4-guided Treatment Interruptions vs Continuous Antiretroviral Therapy in Staccato TrialIn contrast to some other recent studies, the Staccato trial found that structured treatment interruptions guided by CD4 cell count reduced total time on therapy and adverse side effects without increased progression to AIDS or death (The Lancet). Full Article...HAART Followed by Treatment Interruption Provides No Benefit for Patients with Primary HIV InfectionA series of treatment interruptions of increasing length did not improve the ability to suppress HIV without antiretroviral therapy in patients with recent infection. Full Article...Switching from Lopinavir/Ritonavir to Unboosted Atazanavir Lowers LipidsSwitching from combination regimens containing lopinavir/ritonavir (Kaletra) to those with unboosted atazanavir (Reyataz) produced improvement in blood lipid profiles with similar rates of virological suppression. Full Article...HIV Positive Individuals at Greater Risk for Resistant Staph InfectionThe incidence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection is increasing, and MRSA was 18 times more common among HIV positive compared with HIV negative individuals in a recent San Diego study. Full Article... Regards, Vergelpowerusa dot org Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.